SecreFlo(TM) Secretin for Injection
IndicationsNews and EventsPublicationsOrdering Information

Contact UsPrescribing Information

  • NEW INDICATION APPROVED - SECREFLOTM ENABLES IDENTIFICATION OF PANCREATIC DUCTS TO FACILITATE ERCP. The FDA has approved SecreFloTM to aid in the location and cannulation of the pancreatic ducts in patients undergoing ERCP. To read more about using SecreFloTM for this new indication, please visit the Publications page.

  • SecreFloTM is now available for immediate shipment. To place an order please contact your wholesaler or call 1-877-Repligen (877-737-5443).
All information appearing on this site is intended only for healthcare professionals practicing in the United States to provide knowledge and information about SecreFloTM, secretin for injection, and its FDA-approved indications. Repligen Corporation will endeavor to include accurate and up-to-date information on this site, but makes no warranties or representations as to the accuracy or completeness of the contents of this site or of any site linked to this site. For more detailed information regarding SecreFloTM dosing or test administration, please refer to the current Prescribing Information.

© Copyright 2002, Repligen Corporation. All rights reserved.